Samsung Pharm Cash Flow Reinvestment Rate

Latest as of June 2022: 0.48x

Samsung Pharm cash flow reinvestment rate. Samsung Pharm (001360) has a Cash Flow Reinvestment Rate of 0.48x as of June 2022, reinvesting ₩766.26 Million (capex ₩638.30 Million plus investments ₩-127.95 Million) from operating cash flow of ₩1.59 Billion. Explore 001360 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.48x

(Capex + Investments) / Operating CF

Total Reinvested

₩766.26 Million

Capex + Investments

Operating Cash Flow

₩1.59 Billion

KRW

Capital Expenditures

₩638.30 Million

KRW

Cash Flow Reinvestment Rate of Samsung Pharm (2017–2017)

Cash flow reinvestment rate of Samsung Pharm from 2017 to 2017. Historical reinvestment intensity for Samsung Pharm across 1 annual periods. Explore Samsung Pharm (001360) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Samsung Pharm Cash Flow Reinvestment Rate by Year (2017–2017)

Samsung Pharm cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for Samsung Pharm. For the full cash flow conversion analysis, see Samsung Pharm (001360) cash conversion ratio.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2017	1.26x	₩6.51 Billion	₩5.15 Billion	₩6.11 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow